What Particle Analytical Aps does

Particle Analytical ApS is a Denmark-based contract analytical laboratory specializing in solid-state characterization and particle analysis for the pharmaceutical and biopharmaceutical industries. Founded in 2000 by Søren Lund Kristensen and headquartered at DTU Science Park in Hørsholm, the firm operates as a GMP-certified, FDA-inspected testing services provider with approximately 11-50 employees. The company focuses on a narrow set of regulated analytical services — including bioequivalence support, solid form studies, foreign particle identification, method development, troubleshooting, and reverse engineering — that are typically required across the drug development lifecycle from formulation through commercial manufacturing.

The laboratory's service offering is built around a broad instrument portfolio covering X-ray powder diffraction (XRPD), Raman and FTIR spectroscopy, dynamic light scattering (DLS), laser diffraction, polarized light microscopy, scanning electron microscopy with energy-dispersive spectroscopy (SEM-EDS), and related solid-state and particulate techniques. A recent addition is a GMP-compliant Raman microscopy capability launched in October 2024, expanding the regulated testing surface area. The firm follows a project-based B2B contract services model with a standard 10-day turnaround, a 5-day expedited tier, and a next-day rush option; payment terms are 8 days from invoice.

Particle Analytical targets global pharmaceutical and biotechnology clients and positions itself as one of a small number of contract laboratories worldwide with deep specialization in this niche. The business has been recognized as a Danish Gazelle Company (a fast-growth designation), is approaching its 25-year operating anniversary, and was acquired by Kymos Group SL in 2026, indicating consolidation activity in the European analytical CRO market and giving Particle Analytical access to a broader European and South Korean platform.

Name

Particle Analytical Aps

Legal name

Particle Analytical ApS

Website

https://particle.dk

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Particle Analytical ApS is a GMP-certified Danish contract laboratory specializing in solid-state characterization and particle analysis for global pharmaceutical and biopharmaceutical clients, offering XRPD, Raman, DLS, and related regulated analytical services on a project basis.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Analytical Laboratory Services

NAICS

Testing Laboratories and Services (54138), Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule Analytical Development & Method Validation (CMC) (HLAGAHAF)

akta.pro secondary industry

Release Testing & Batch Certification (QC) (HLAGADAC)

Keywords

• Contract analytical laboratory
• Solid-state characterization
• Pharmaceutical particle analysis
• GMP analytical testing
• Bioequivalence studies

Headquarters

HQ city

Hørsholm

HQ country

Denmark

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. GMP Analytical and Testing Laboratory Services: Contract laboratory providing GMP-compliant analytical testing services across the pharmaceutical value chain. Services include solid-state characterization, method development and validation, bioequivalence studies, troubleshooting investigations, and quality control measurements. Revenue is generated through project-based testing fees, method development contracts, and ongoing analytical service agreements. Pricing is quote-based and varies by service complexity and turnaround time requirements.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Particle Analytical is a GMP-certified contract laboratory specializing in solid-state characterization and particle analysis services for the pharmaceutical industry. The company provides end-to-end analytical support across the pharmaceutical value chain, including particle characterization, solid form screening, bioequivalence studies, method development and validation, reverse engineering, foreign particle identification, troubleshooting, and supplier material comparison, using advanced techniques such as XRPD, Raman Confocal Microscopy (including MDRS), DLS, laser diffraction, DSC, SEM-EDX, and BET.

Product overview

Particle Analytical is a GMP-certified contract laboratory specializing in solid-state characterization and particle analysis services for the pharmaceutical industry. The company offers a comprehensive portfolio of analytical services organized around core offerings: Particle/Solid State Characterization, Solid Form Studies/Screening, Bioequivalence Services, Method Development & Validation, Pharmaceutical Reverse Engineering, Foreign Particle Identification, Troubleshooting, and Supplier Material Comparison. These services are delivered through advanced analytical techniques including X-ray Powder Diffraction (XRPD), Raman Confocal Microscopy (including MDRS), Laser Diffraction, Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC), Thermogravimetric Analysis (TGA), SEM-EDX, FTIR, BET, and various particle characterization methods. The company supports pharmaceutical clients across the entire drug development lifecycle from early discovery through commercialization, providing regulatory-compliant data for FDA and EMA submissions.

Differentiator

Problem solved

Functional benefit

Products and services

• Particle Characterization / Solid State Characterization Comprehensive analysis of physical and structural properties of pharmaceutical solids including APIs, excipients, and finished products, covering polymorphism, crystallinity, particle morphology, and dissolution properties for pharmaceutical companies.
• Solid Form Studies / Solid Form Screening Systematic investigation of different physical forms of APIs including polymorphs, hydrates, salts, co-crystals, and amorphous forms to identify optimal forms for bioavailability, stability, and manufacturability for pharmaceutical developers.
• Bioequivalence Services Demonstration of therapeutic equivalence between generic and reference drug products using solid-state characterization and Morphologically Directed Raman Spectroscopy (MDRS) for FDA and EMA compliance, targeted at generic drug developers.
• Method Development & Validation Design, optimization, validation, transfer, and implementation of analytical methods under GMP conditions aligned with ICH Q2(R1), USP, and EMA guidelines for pharmaceutical characterization.
• Pharmaceutical Reverse Engineering Systematic analysis of existing drug products to determine composition, manufacturing process, and performance-related attributes supporting generic development and quality investigations.
• Foreign Particle Identification Identification and characterization of foreign particles in pharmaceutical products using Raman spectroscopy, microscopy, SEM-EDX, FTIR, and XRPD to determine contamination sources and ensure patient safety.
• Troubleshooting Services Root cause analysis and resolution of manufacturing deviations, quality defects, formulation issues, and production challenges using comprehensive analytical techniques under GMP conditions.
• Supplier Material Comparison Evaluation of solid-state properties from different suppliers including flowability, compaction behavior, surface area, crystalline form, particle sizing, and morphology for consistent product performance.

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• Kymos Group SLcoreStrategic or Co-development Partner · 27 February 2026Particle Analytical joined Kymos Group after 25 years of independent operation. Kymos Group is a European contract research organization (CRO) headquartered in Barcelona, Spain, with laboratories in Spain, Italy, Germany, and an affiliate in South Korea. The integration represents a natural evolution built on shared commitment to scientific excellence, regulatory rigor, and long-term client partnerships. Particle Analytical gains access to broader international infrastructure and complementary scientific expertise, strengthening the Group's position in solid-state and particle characterization.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• SGS: Global testing, inspection, and certification company with life sciences and pharmaceutical analytical services divisions. Overlaps with Particle Analytical in pharma GMP testing and quality control, but SGS operates at much larger scale and across many other verticals.
• Eurofins Scientific: Global leader in bioanalytical and pharmaceutical testing services with extensive GMP laboratory footprint across Europe. Broad incumbent offering overlapping analytical testing capabilities including particle characterization and solid-state analysis, though as part of a much wider testing portfolio rather than a niche specialization.
• Intertek: Global quality assurance and testing services provider with pharmaceutical analytical offerings. Comparable as a broad incumbent serving pharmaceutical manufacturers with GMP analytical testing, though Intertek's pharmaceutical practice is one of many service lines versus Particle Analytical's exclusive specialization.
• Charles River Laboratories: Major contract research organization providing discovery, safety assessment, and manufacturing support to pharma and biotech. Comparable as a broad incumbent CRO serving overlapping pharmaceutical clients, though Particle Analytical's solid-state niche is a fraction of Charles River's full offering.

Direct peers

• Alcami Corporation: US-based contract development and manufacturing organization offering analytical testing, method development, and GMP laboratory services to pharmaceutical clients. Direct peer in the pharmaceutical analytical services space with overlapping GMP testing capabilities and similar mid-sized CRO positioning.
• Cambrex: CDMO specializing in small-molecule API development and analytical services for the pharmaceutical industry. Comparable because it offers GMP-compliant analytical method development, validation, and solid-state characterization services to overlapping pharma clients across drug development and commercialization.
• Kymos Group: Parent company of Particle Analytical since 2026; Barcelona-headquartered European CRO providing analytical, bioanalytical, and CMC services to pharma and biotech. Direct peer as the integrated platform combining Kymos' broader analytical portfolio with Particle Analytical's solid-state and particle characterization niche.
• Crystallics: Netherlands-based contract laboratory specializing in solid-state research, polymorphism screening, and crystallization services for pharmaceuticals. Highly comparable as a niche CRO offering overlapping services to Particle Analytical including solid form screening and particle characterization for drug development.

Emerging players

• Pharmaterials: UK-based contract laboratory providing pharmaceutical solid-state and pre-formulation services including polymorphism, salt selection, and particle characterization. Emerging specialist peer with significant overlap to Particle Analytical's niche solid-state focus, serving similar pharma R&D customers.
• Avomeen Analytical Services: US-based contract analytical laboratory offering GMP testing, method development, and characterization services to pharmaceutical manufacturers. Emerging specialist peer with comparable analytical service breadth though broader industry focus than Particle Analytical's solid-state-exclusive positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/particle-analytical-aps

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Particle Analytical Aps